100.90
price up icon1.89%   1.87
after-market Handel nachbörslich: 100.90
loading
Schlusskurs vom Vortag:
$99.03
Offen:
$99.8
24-Stunden-Volumen:
967.92K
Relative Volume:
0.78
Marktkapitalisierung:
$11.34B
Einnahmen:
$2.77B
Nettoeinkommen (Verlust:
$286.61M
KGV:
42.94
EPS:
2.35
Netto-Cashflow:
$524.11M
1W Leistung:
+3.28%
1M Leistung:
+12.96%
6M Leistung:
-9.91%
1J Leistung:
-1.09%
1-Tages-Spanne:
Value
$98.82
$101.17
1-Wochen-Bereich:
Value
$95.97
$102.18
52-Wochen-Spanne:
Value
$87.70
$129.50

Revvity Inc Stock (RVTY) Company Profile

Name
Firmenname
Revvity Inc
Name
Telefon
781-663-6900
Name
Adresse
77 4TH AVENUE, WALTHAM
Name
Mitarbeiter
11,000
Name
Twitter
Name
Nächster Verdiensttermin
2025-04-28
Name
Neueste SEC-Einreichungen
Name
RVTY's Discussions on Twitter

Vergleichen Sie RVTY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
RVTY
Revvity Inc
100.90 11.34B 2.77B 286.61M 524.11M 2.35
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
427.76 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
202.50 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
542.71 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
120.66 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
164.65 27.64B 15.50B 1.33B 2.16B 7.34

Revvity Inc Stock (RVTY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-01 Hochstufung UBS Neutral → Buy
2025-01-10 Herabstufung Bernstein Outperform → Mkt Perform
2024-12-13 Hochstufung BofA Securities Neutral → Buy
2024-10-15 Hochstufung Barclays Equal Weight → Overweight
2024-08-28 Eingeleitet Wells Fargo Equal Weight
2024-07-08 Eingeleitet Leerink Partners Outperform
2024-06-03 Fortgesetzt Jefferies Hold
2024-01-16 Herabstufung UBS Buy → Neutral
2024-01-04 Hochstufung Evercore ISI In-line → Outperform
2023-12-19 Eingeleitet Wells Fargo Equal Weight
2023-12-13 Eingeleitet Wolfe Research Peer Perform
2023-09-28 Eingeleitet Bernstein Outperform
2023-07-19 Eingeleitet Raymond James Outperform
2023-05-23 Fortgesetzt Goldman Buy
Alle ansehen

Revvity Inc Aktie (RVTY) Neueste Nachrichten

pulisher
Jun 17, 2025

Revvity Inc. stock outperforms competitors despite losses on the day - MarketWatch

Jun 17, 2025
pulisher
Jun 16, 2025

How To Trade (RVTY) - news.stocktradersdaily.com

Jun 16, 2025
pulisher
Jun 15, 2025

Are Revvity, Inc.'s (NYSE:RVTY) Mixed Financials Driving The Negative Sentiment? - simplywall.st

Jun 15, 2025
pulisher
Jun 12, 2025

Revvity introduces new IVD reference standards for monitoring oncology diagnostic testing workflows - SelectScience

Jun 12, 2025
pulisher
Jun 10, 2025

Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch

Jun 10, 2025
pulisher
Jun 10, 2025

Revvity at Goldman Sachs Conference: Diagnostics and Software Focus By Investing.com - Investing.com Canada

Jun 10, 2025
pulisher
Jun 10, 2025

Revvity at Goldman Sachs Conference: Diagnostics and Software Focus - Investing.com

Jun 10, 2025
pulisher
Jun 10, 2025

Transcript : Revvity, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08 - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Revvity To Present At Goldman Sachs Global Healthcare Conference; Webcast At 8:00 AM ET - Nasdaq

Jun 10, 2025
pulisher
Jun 08, 2025

Wellington Management Group LLP Has $743,000 Stock Holdings in Revvity, Inc. (NYSE:RVTY) - Defense World

Jun 08, 2025
pulisher
Jun 04, 2025

(RVTY) Long Term Investment Analysis - news.stocktradersdaily.com

Jun 04, 2025
pulisher
Jun 03, 2025

Revvity gets FDA nod for its automated tuberculosis test - MSN

Jun 03, 2025
pulisher
Jun 02, 2025

4 Mass. Rulings You May Have Missed In May - Law360

Jun 02, 2025
pulisher
Jun 02, 2025

Revvity (RVTY) Introduces New Mimix Standards for Improved IVD Testing | RVTY Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

New Cancer Testing Standards from Revvity Promise More Accurate Diagnostic Results for Oncology Labs - Stock Titan

Jun 02, 2025
pulisher
May 30, 2025

Insider Sell: Michelle Mcmurry-heath Sells 600 Shares of Revvity Inc (RVTY) - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Does The Market Have A Low Tolerance For Revvity, Inc.'s (NYSE:RVTY) Mixed Fundamentals? - Yahoo

May 30, 2025
pulisher
May 30, 2025

Millennium Management LLC Trims Position in Revvity, Inc. (NYSE:RVTY) - Defense World

May 30, 2025
pulisher
May 28, 2025

Shareholders in Revvity (NYSE:RVTY) are in the red if they invested three years ago - simplywall.st

May 28, 2025
pulisher
May 27, 2025

Revvity Inc (RVTY) Shares Up 3.52% on May 27 - GuruFocus

May 27, 2025
pulisher
May 26, 2025

Revvity, Inc. (NYSE:RVTY) Shares Purchased by Cetera Investment Advisers - Defense World

May 26, 2025
pulisher
May 25, 2025

RVTY Stock Falls Despite the Latest Launch of Automated Instrument - MSN

May 25, 2025
pulisher
May 24, 2025

Revvity (NYSE:RVTY) Cut to “Hold” at Wall Street Zen - Defense World

May 24, 2025
pulisher
May 23, 2025

Zacks Research Forecasts Revvity’s Q1 Earnings (NYSE:RVTY) - Defense World

May 23, 2025
pulisher
May 23, 2025

Revvity’s EUROIMMUN unveils new fully automated instrument for specialty testing - SelectScience

May 23, 2025
pulisher
May 23, 2025

Revvity’s EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing - Technology Networks

May 23, 2025
pulisher
May 22, 2025

Enhancing Laboratory Efficiency with Revvity's IDS i20™ Platform - Lab Manager

May 22, 2025
pulisher
May 22, 2025

Is Wall Street Bullish or Bearish on Revvity Stock? - inkl

May 22, 2025
pulisher
May 22, 2025

Is Wall Street Bullish Or Bearish On Revvity Stock? - Barchart.com

May 22, 2025
pulisher
May 22, 2025

Revvity (RVTY) Receives Affirmed Buy Rating with Promising Outlo - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Revvity (RVTY) Receives Affirmed Buy Rating with Promising Outlook | RVTY Stock News - GuruFocus

May 22, 2025
pulisher
May 21, 2025

Sustainable chemistry in India fueling growth with digital and AI innovation: Revvity Signals - Indian Chemical News

May 21, 2025
pulisher
May 21, 2025

Ameriprise Financial Inc. Increases Stock Position in Revvity, Inc. (NYSE:RVTY) - Defense World

May 21, 2025
pulisher
May 20, 2025

Revvity announces launch of new fully automated instrument for specialty testing - BioSpectrum India

May 20, 2025
pulisher
May 19, 2025

Revvity's EUROIMMUN Unveils New Fully Automated Instrument for S - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Revvity's EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing | RVTY Stock News - GuruFocus

May 19, 2025
pulisher
May 15, 2025

Element Biosciences Welcomes Dr. Madhuri Hegde to its Board of Directors - Business Wire

May 15, 2025
pulisher
May 14, 2025

Revvity Signals Software Inc. v. Cloud Software Group Inc. - Cornerstone Research

May 14, 2025
pulisher
May 14, 2025

Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

May 14, 2025
pulisher
May 14, 2025

Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight - GlobeNewswire Inc.

May 14, 2025
pulisher
May 14, 2025

Shareholders Will Be Pleased With The Quality of Revvity's (NYSE:RVTY) Earnings - Yahoo

May 14, 2025
pulisher
May 13, 2025

Revvity at Bank of America 2025 Healthcare Conference: Navigating Tariffs and Growth - Investing.com India

May 13, 2025
pulisher
May 13, 2025

Revvity To Present At Bank Of America Global Healthcare Conference 2025; Webcast At 12:20 PM ET - Nasdaq

May 13, 2025
pulisher
May 12, 2025

Revvity beats quarterly estimates on steady demand for medical equipment - MSN

May 12, 2025
pulisher
May 12, 2025

Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

RVTY Q1 Earnings Call: Resilient Performance Amid Academic and Tariff Headwinds, Software and Diagnostics Shine - Yahoo Finance

May 12, 2025
pulisher
May 09, 2025

Revvity: Despite Facing Multiple Headwinds, Shares Are A Buy (NYSE:RVTY) - Seeking Alpha

May 09, 2025
pulisher
May 07, 2025

High Content Screening Market Global Forecasts 2025-2030 - GlobeNewswire

May 07, 2025
pulisher
May 07, 2025

High Content Screening Market Global Forecasts 2025-2030 with Danaher, Revvity, BD, Carl Zeiss, Merck, and Thermo Fisher Scientific Dominating the $2.19 Billion Market - Yahoo Finance

May 07, 2025
pulisher
May 06, 2025

Revvity joins peers Thermo Fisher, Danaher in tariff warning, maintains profit outlook - MSN

May 06, 2025
pulisher
May 05, 2025

Revvity Announces Financial Results for the First Quarter of 2025 - ADVFN

May 05, 2025

Finanzdaten der Revvity Inc-Aktie (RVTY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research DGX
$176.60
price down icon 1.52%
diagnostics_research WAT
$351.92
price down icon 1.43%
diagnostics_research LH
$260.00
price down icon 1.61%
$161.57
price up icon 0.53%
diagnostics_research MTD
$1,205.65
price up icon 0.03%
diagnostics_research IQV
$164.65
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):